SEC Form 4 · accession 0001645627-18-000013
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Feb 27, 2018
Accepted (ET)
Mar 2, 2018 · 7:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2018 | P | 1,000 | $0.042 | A | 24,833,189 | D | |
| Common Stock | Feb 28, 2018 | P | 1,000 | $0.039 | A | 24,834,189 | D | |
| Common Stock | Feb 28, 2018 | P | 1,000 | $0.039 | A | 24,835,189 | D | |
| Common Stock | Feb 28, 2018 | P | 1,000 | $0.0389 | A | 24,836,189 | D | |
| Common Stock | Feb 28, 2018 | P | 1,000 | $0.0404 | A | 24,837,189 | D | |
| Common Stock | Feb 28, 2018 | P | 1,000 | $0.0404 | A | 24,838,189 | D | |
| Common Stock | Feb 28, 2018 | P | 1,000 | $0.0408 | A | 24,839,189 | D | |
| Common Stock | Feb 28, 2018 | P | 1,000 | $0.0404 | A | 24,840,189 | D | |
| Common Stock | Feb 28, 2018 | P | 1,000 | $0.0405 | A | 24,841,189 | D | |
| Common Stock | Feb 28, 2018 | P | 1,000 | $0.0404 | A | 24,842,189 | D | |
| Common Stock | Feb 28, 2018 | P | 1,000 | $0.0404 | A | 24,843,189 | D | |
| Common Stock | Feb 28, 2018 | P | 1,000 | $0.0408 | A | 24,844,189 | D | |
| Common Stock | Feb 28, 2018 | P | 1,000 | $0.0409 | A | 24,845,189 | D | |
| Common Stock | Mar 1, 2018 | P | 1,000 | $0.0414 | A | 24,846,189 | D | |
| Common Stock | Mar 1, 2018 | P | 1,000 | $0.041 | A | 24,847,189 | D |
Table II — derivative securities
No Table II lines on this filing.